Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
Authors
Keywords
-
Journal
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-12-20
DOI
10.1002/ccd.28654
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials
- (2018) Sripal Bangalore et al. CIRCULATION
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
- (2018) Hector M. Garcia-Garcia et al. CIRCULATION
- Long-term safety of bioresorbable scaffolds: insights from a network meta-analysis including 91 trials
- (2018) Si-Hyuck Kang et al. EuroIntervention
- Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and Evolution
- (2018) Davide Capodanno Korean Circulation Journal
- 2018 ESC/EACTS Guidelines on myocardial revascularization
- (2018) Franz-Josef Neumann et al. EUROPEAN HEART JOURNAL
- Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year Results
- (2018) David E. Kandzari et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fourth Universal Definition of Myocardial Infarction (2018)
- (2018) Kristian Thygesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial
- (2018) Thomas Pilgrim et al. LANCET
- Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial
- (2018) Clemens von Birgelen et al. LANCET
- Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions
- (2017) Koen Teeuwen et al. JACC-Cardiovascular Interventions
- 10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents
- (2017) Anders M. Galløe et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial
- (2017) David E Kandzari et al. LANCET
- Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial
- (2017) Si-Hyuck Kang et al. EuroIntervention
- Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis
- (2016) Daisuke Nakamura et al. Circulation-Cardiovascular Interventions
- Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial
- (2016) Kyohei Yamaji et al. EUROPEAN HEART JOURNAL
- Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds
- (2016) Si-Hyuck Kang et al. JACC-Cardiovascular Interventions
- Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial
- (2016) Clemens von Birgelen et al. LANCET
- Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: Results of the Randomized BIOFLOW-II Trial
- (2015) S. Windecker et al. Circulation-Cardiovascular Interventions
- Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment
- (2015) Fumiyuki Otsuka et al. EUROPEAN HEART JOURNAL
- Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary
- (2015) Robert A. Byrne et al. EUROPEAN HEART JOURNAL
- Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial
- (2015) Bent Raungaard et al. LANCET
- Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial
- (2014) Thomas Pilgrim et al. LANCET
- Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: Final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial
- (2013) Sorin J. Brener et al. AMERICAN HEART JOURNAL
- Coronary stents: novel developments
- (2013) Giulio G Stefanini et al. HEART
- Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial
- (2013) Joo Myung Lee et al. Trials
- Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial
- (2012) Edoardo Camenzind et al. LANCET
- Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation
- (2012) Gerd Bayer et al. THROMBOSIS AND HAEMOSTASIS
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
- (2011) Kumaran Kolandaivelu et al. CIRCULATION
- Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2009) Stefan James et al. AMERICAN HEART JOURNAL
- Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation
- (2009) Giora Weisz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now